Table 1. Patients' characteristics.

No.	Age	Sex	Sites ofsarcoidosis	Clinical findings	68Ga-DOTATOC	CMR(T2/LGE)	Clinical follow-up
1	47	F	LN, lung	Palpitations	negative	negative/negative	unremarkable
2	54	F	LN, lung	Bifascicular block, cardiac enzymes, HF, VPB	positive	positive/positive	VT, ICD
3	52	M	LN, lung	Cardiac enzymes, chest pain	negative	positive/positive	Initiation of corticosteroids
4	41	M	Lung	Palpitations	negative	negative/negative	unremarkable
5	52	F	LN, lung	Palpitations, SOB	negative	negative/negative	unremarkable
6	51	F	LN, lung, nasal sinus, spleen	Palpitatons, SOB	negative	negative/negative	Initiation of corticosteroids, azathioprine
7	75	M	LN, lung	SOB, palpitations, LAFB	positive	positive/positive	Initiation of corticosteroids, azathioprine
8	42	F	Bone, LN, liver, lung, spleen	HF, RBBB	positive	positive/positive	VT, cardiogenic shock
9	60	F	-	HF, LBBB	negative	negative/negative	unremarkable
10	42	M	LN, lung, skin	VT	positive	positive/positive	VT, ICD
11	55	F	LN, liver, lung, omentum	HF, LBBB	negative	positive/positive	unremarkable
12	65	M	LN, lung, parotidea, uvea	VPB	positive	positive/positive	unremarkable
13	52	M	LN, lung	Known CS	positive	positive/positive	unremarkable
14	71	F	LN, lung, skin	Known CS	negative	positive/positive	unremarkable
15	25	F	LN, lung	VT, HF	positive	positive/positive	VT, lifevest

CS = cardiac sarcoidosis, F = female, HF = heart failure, ICD = implantable cardioverter defibrillator, LAFB = left anterior fascicular block, LN = lymph nodes, M = male, RBBB = right bundle branch block, SOB = shortness of breath, VPB = ventricular premature beats, VT = ventricular tachycardia